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S U M M A R Y
Objectives: To provide data on severe bacteremic community-acquired infections due to Klebsiella
pneumoniae in New Caledonia.
Methods: All patients admitted with bacteremic community-acquired infections due to K. pneumoniae at
the only tertiary medical center in New Caledonia, from 2008 to 2013, were included retrospectively in
this study. Clinical and microbiological characteristics were analyzed, as well as risk factors for mortality.
Results: The characteristics of 119 patients were analyzed. The most common clinical presentation was
urinary tract infection (40 cases, 33%), followed by pneumonia (28 cases, 23%), deep abscesses (15 cases,
13%), liver abscess (12 cases, 9%), meningitis in (ﬁve cases, 4%), and endophthalmitis (two cases, 1%).
Multiple localizations were reported in 18 cases (15%) and isolated bacteremia was reported in 22 cases
(18%). The overall mortality rate was 22% (26/119) and the mortality rate in the intensive care unit was
33% (14/42). Renal impairment, chronic liver disease, pneumonia, and isolated bacteremia were
independent risk factors for mortality.
Conclusions: K. pneumoniae is a dominant cause of severe community-acquired bacteremic infection in
New Caledonia. Physicians should be aware of the poor prognosis of any patient with a bacteremic K.
pneumoniae infection and should monitor patients presenting with risk factors closely.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
Contents lists available at ScienceDirect
International Journal of Infectious Diseases
jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Klebsiella pneumoniae is a common Gram-negative bacterium
with worldwide distribution, classically causing nosocomial
infections, community-acquired pneumonia, liver abscess, and
urinary tract infections, mostly in patients with underlying
diseases.1–4 However, in speciﬁc regions such as Taiwan, K.
pneumoniae bacteremia is more likely to be community-acquired
compared with the USA, Australia, South Africa, Europe, and
Argentina.5 Moreover, this pathogen has recently emerged as a
major cause of a severe infectious syndrome including liver abscess
without underlying hepatobiliary disease, potentially associated
with metastatic localizations such as meningitis or endophthal-
mitis.6,7 This syndrome is considered a serious public health
problem in Southeast Asia.8 Risk factors for such infections include* Corresponding author.
E-mail address: guerriergilles@gmail.com (G. Guerrier).
http://dx.doi.org/10.1016/j.ijid.2015.10.013
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).diabetes mellitus and a potential genetic predisposition.6 The
K. pneumoniae isolates from severe invasive infections are often
hypermucoviscous and frequently belong to the capsular serotype
K1 or K2.9,10
To date, severe community-acquired K. pneumoniae infections
have not been explored in New Caledonia. The aim of the present
study was to report the epidemiology, clinical presentations,
microbiological features, and outcomes through a retrospective
cohort study of adult patients admitted to the only tertiary referral
hospital for bacteremic community-acquired infections due to K.
pneumoniae in New Caledonia.
2. Methods
2.1. Patient selection
Microbiology records were used to identify consecutive
patients with bacteremia due to K. pneumoniae admitted between
January 2008 and December 2013 to the Centre Hospitalierciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Clinical characteristics at presentation and outcome of patients with bacteremic
infection due to Klebsiella pneumoniae, New Caledonia 2008–2013
Variables (N = 119) n (%) or mean (range)
Sex
Male 51 (43)
Female 68 (57)
Age, years 58 (44–70)
Ethnicity
Melanesian 57 (48)
Asian 9 (7)
Other 34 (45)
Comorbidities
Diabetes mellitus 45 (38)
Renal impairment 11 (9)
Chronic liver disease 17 (14)
Immunosuppressive treatment 11 (9)
Outcome
Death 26 (22)
Use of vasopressors 23 (19)
ICU length of stay, days 8 (2–13)
Duration of hospitalization, days 15 (7–60)
ICU, intensive care unit.
Table 2
Site of infection among patients with Klebsi-
ella pneumoniae identiﬁed in blood culture,
New Caledonia 2008–2013
Site of infection (N = 119) n (%)
Urinary tract infection 40 (33)
Pneumonia 28 (23)
Deep abscess 15 (13)
Liver abscess 12 (9)
Meningitis 5 (4)
Endophthalmitis 2 (1)
Soft tissue infection 4 (3)
Multiple localizations 18 (15)
Isolated bacteremia 22 (18)
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medical records of patients with a community-acquired bacter-
emic infection were reviewed. Community-acquired infection was
deﬁned as the acquisition of the infection outside a hospital, long-
term care facility, or nursing home. Bacteremia was deﬁned as the
presence of at least one blood culture sampled within 48 h of
presentation in the hospital yielding a pathogen presumed to be
the cause of the infection. The diagnosis was conﬁrmed by two
infectious diseases specialists. The institutional review board of
New Caledonia approved this study.
2.2. Data collection and deﬁnition
The following data were collected for each patient: demo-
graphic characteristics, underlying diseases or risk factors, clinical
variables present at admission, laboratory data, empirical and
concordant antibiotics received, admission to the intensive care
unit (ICU), days of hospitalization, and in-hospital death. Concor-
dant antibiotic therapy was deﬁned as the initial antibiotic therapy
including any antibiotic to which the infecting organism was
sensitive based on the microbiology report.
2.3. Microbiology laboratory procedures
The VITEK 2 system (bioMe´rieux, Marcy l’Etoile, France) was
used to conﬁrm bacterial identiﬁcations. The antimicrobial
susceptibility of K. pneumoniae was tested by disk diffusion
method and results were interpreted in accordance with the
guidelines of the Clinical and Laboratory Standards Institute (CLSI;
M100-S17 2007). Extended-spectrum beta-lactamase (ESBL)
production was determined using a double-disk potentiation test
with amoxicillin–clavulanic acid and cefotaxime, ceftazidime, or
cefepime using the ESBL-positive results of the VITEK 2 N131 card.
2.4. Statistical analysis
Contingency data were analyzed by two-tailed Chi-square test
or Fisher’s exact test, and continuous data were analyzed by
Student t-test or the Mann–Whitney U-test. A p-value of <0.05 was
considered to be statistically signiﬁcant, and all probabilities were
two-tailed. Variables with p-values of <0.10 on univariate analysis
were subsequently entered into the multivariate analysis. The
multivariate logistic regression model was used to evaluate risk
factors for mortality in bacteremic infections caused by K.
pneumoniae. All statistical analyses were performed using Stata
version 12.0 software (StataCorp LP, College Station, TX, US).
3. Results
The characteristics of 119 patients were analyzed. Demographic
characteristics and clinical presentations are shown in Table 1. A
majority (55%) of the patients were younger than 65 years of age.
The most common clinical presentation was urinary tract infection
(40 cases, 33%), followed by pneumonia (28 cases, 23%), deep
abscesses (15 cases, 13%), liver abscess (12 cases, 9%), meningitis
(ﬁve cases, 4%), and endophthalmitis (two cases, 1%). Multiple
localizations were reported in 18 cases (15%) and isolated
bacteremia was reported in 22 cases (18%) (Table 2).
The mean duration of hospitalization was 15 days (95%
conﬁdence interval (CI) 10–22 days) and the mean duration
between the onset of symptoms and hospitalization was 2 days
(95% CI 1–4 days). Forty-two (35%) patients were admitted to the
ICU. The mean duration of stay in the ICU was 32 days (95% CI
12–44 days). Twenty-three (19%) patients presented with septic
shock. Concordant antibiotic treatment was given to 85 (90%)
patients with bacteremic K. pneumoniae infection according to theresults of susceptibility testing. ESBL-related resistance pheno-
types were identiﬁed in four (3%) cases. The overall mortality rate
was 22% (26/119) and the mortality rate in the ICU was 33% (14/
42). Factors associated with mortality in bacteremic K. pneumoniae
infection are listed in Table 3. Renal impairment (odds ratio (OR)
2.7, 95% CI 1.1–3.5; p = 0.03), chronic liver disease (OR 2.9, 95% CI
2.1–5.3; p < 0.001), pneumonia (OR 2.9, 95% CI 2.0–5.9; p < 0.001),
and isolated bacteremia (OR 2.5, 95% CI 1.2–5.1; p = 0.02) were
independent risk factors for mortality.
3.1. Susceptibility testing
Out of the 119 K. pneumoniae isolates, 64 (54%) showed uniform
resistance to ampicillin, ticarcillin, and piperacillin and suscepti-
bility to a number of classes of antibiotic, including clavulanic acid,
quinolones, cephalosporins, co-trimoxazole, macrolides, and
aminoglycosides (deﬁning the wild phenotype). Four (3%) isolates
showed ESBL production.
4. Discussion
K. pneumoniae is a major cause of infection worldwide,
including in New Caledonia. The present study further highlights
the role of K. pneumoniae as a dominant pathogen in community-
acquired bacteremic infections in the Paciﬁc Region. Although
conducted in a single institution, the ﬁndings of the present study
are compatible with those of previous studies conducted in the
Table 3
Risk factors associated with mortality among patients with Klebsiella pneumoniae
identiﬁed in blood culture, New Caledonia 2008–2013
Variable Univariate analysis Multivariate analysis
RR (95% CI) p-Value RR (95% CI) p-Value
Age 3.1 (0.6–4.9) 0.33
Sex 1.0 (0.8–1.9) 0.67
Diabetes 0.3 (0.1–2.2) 0.59
Renal impairment 2.5 (1.2–5.1) 0.04 2.7 (1.1–3.5) 0.03
Chronic liver disease 3.4 (2.8–5.9) <0.001 2.9 (2.1–5.3) <0.001
Pneumonia 3.6 (2.9–6.9) <0.001 2.9 (2.0–5.9) <0.001
Isolated bacteremia 2.2 (1.3–5.0) 0.02 2.5 (1.2–5.1) 0.02
ESBL phenotype 1.2 (0.7–2.9) 0.77
Concordant antibiotherapy 0.7 (0.5–3.9) 0.8
RR, relative risk; CI, conﬁdence interval; ESBL, extended-spectrum beta-lactamase.
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K. pneumoniae infections in this area.11
Similarly to the present study, other studies have described
steatosis and liver cirrhosis as the main risk factors for Klebsiella
primary liver abscesses.12,13 Moreover, bacteremic community-
acquired pneumonia due to K. pneumoniae is signiﬁcantly
associated with alcoholism.5 Another study has found alcoholism
to be a risk factor for a poor outcome of bacteremic community-
acquired pneumonia due to K. pneumoniae.14 Although chronic
alcoholism was reported in only seven patients in the present
study, with no association with mortality, it is likely that this
comorbidity was under-reported since chronic alcoholism is
endemic in New Caledonia.15
Another striking ﬁnding is that isolated bacteremia was an
independent risk factor for mortality. This result suggests that the
underlying cause of bacteremia should be scrutinized with
attention, including liver abscess. The mortality rate from
bacteremic infection due to K. pneumoniae in those admitted to
the ICU was high (33%) in this study, despite appropriate empiric
antibiotics and supportive care being provided in most cases. A
previous study found that the ﬁrst 48 h in the development of
community-acquired pneumonia are critical.16 Importantly, the
time lag between symptom onset and the initiation of anti-
biotherapy was found to be signiﬁcantly associated with mortality,
which has been proposed as a major determinant of the outcome in
severe infections.17 Likewise, physicians should be aware of the
high mortality rate in patients with bacteremic infections due to K.
pneumoniae and should monitor patients more closely. Knowledge
of the different characteristics of K. pneumoniae bacteremia
infection is of great importance for physicians in endemic areas
such as New Caledonia. It is also vital for the medical community in
which physicians are constantly faced with the diagnostic and
prognostic challenges of severely infected patients with uncom-
mon pathogens.
A few limitations of this study deserve careful consideration.
First, due to the retrospective nature of the study, there were some
missing data, as illustrated by the lack of information related to
past medical history. Second, therapeutic strategies (including
antimicrobial therapy) were not standardized. Third, it was not
possible to study the phenotypic and genotypic characteristics of
the K. pneumoniae in this analysis (including K1 and K2 serotypes,hypermucoviscosity phenotype, and the aerobactin rmpA genes),
and strain speciﬁcities seem to be a major element of metastatic
localization10 and severity of infection.9 This requires speciﬁc
investigations, which were not performed routinely. As not all of
the patients were admitted to the ICU, the interest of such
predictor tools remains to be demonstrated in the context of
bacteremia due to K. pneumoniae.
In conclusion, K. pneumoniae is a dominant cause of severe
bacteremic infection in the study tertiary-care hospital in New
Caledonia. Bacteremia infections due to K. pneumoniae are
associated with a high mortality, despite an excellent proportion
of initial adequate antibiotherapy in New Caledonia. Physicians
should be aware of the poor prognosis of any patient with a
bacteremic K. pneumoniae infection and should monitor these
patients closely. In the future, the determination of factors related
to the host, i.e., genetic susceptibility, and to bacteria, i.e.,
virulence, is likely to be crucial for a better understanding of the
pathophysiology of invasive infections due to K. pneumoniae.
Conﬂict of interest: None declared.
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